161 related articles for article (PubMed ID: 38082306)
1. C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome.
You D; Nie K; Wu X; Weng M; Yang L; Chen Y; Cui J; Wan J
J Transl Med; 2023 Dec; 21(1):904. PubMed ID: 38082306
[TBL] [Abstract][Full Text] [Related]
2. C3aR contributes to unilateral ureteral obstruction-induced renal interstitial fibrosis via the activation of the NLRP3 inflammasome.
You D; Weng M; Wu X; Nie K; Cui J; Chen Y; Yang L; Wan J
Life Sci; 2022 Nov; 308():120905. PubMed ID: 36041502
[TBL] [Abstract][Full Text] [Related]
3. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
Seo JB; Choi YK; Woo HI; Jung YA; Lee S; Lee S; Park M; Lee IK; Jung GS; Park KG
Diabetes Metab J; 2019 Dec; 43(6):830-839. PubMed ID: 30877711
[TBL] [Abstract][Full Text] [Related]
4. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.
Wang W; Wang X; Chun J; Vilaysane A; Clark S; French G; Bracey NA; Trpkov K; Bonni S; Duff HJ; Beck PL; Muruve DA
J Immunol; 2013 Feb; 190(3):1239-49. PubMed ID: 23264657
[TBL] [Abstract][Full Text] [Related]
5. Protection of hUC-MSCs against neuronal complement C3a receptor-mediated NLRP3 activation in CUMS-induced mice.
Li J; Tian S; Wang H; Wang Y; Du C; Fang J; Wang X; Wang Y; Gong Z; Yan B; Wang M
Neurosci Lett; 2021 Jan; 741():135485. PubMed ID: 33161108
[TBL] [Abstract][Full Text] [Related]
6. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
7. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
8. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
[TBL] [Abstract][Full Text] [Related]
9. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X
Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100
[TBL] [Abstract][Full Text] [Related]
11. Psoralen Alleviates Renal Fibrosis by Attenuating Inflammasome-Dependent NLRP3 Activation and Epithelial-Mesenchymal Transition in a Mouse Unilateral Ureteral Obstruction Model.
Lee TW; Bae E; Kim JH; Jung MH; Park DJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685978
[TBL] [Abstract][Full Text] [Related]
12. The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis.
Alyaseer AAA; de Lima MHS; Braga TT
Front Immunol; 2020; 11():883. PubMed ID: 32508821
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells.
Li X; Yan X; Wang Y; Wang J; Zhou F; Wang H; Xie W; Kong H
Exp Cell Res; 2018 Jan; 362(2):489-497. PubMed ID: 29258746
[TBL] [Abstract][Full Text] [Related]
14. Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway.
Nam SA; Kim WY; Kim JW; Park SH; Kim HL; Lee MS; Komatsu M; Ha H; Lim JH; Park CW; Yang CW; Kim J; Kim YK
Cell Death Dis; 2019 Jan; 10(2):78. PubMed ID: 30692509
[TBL] [Abstract][Full Text] [Related]
15. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-β signaling pathway on interstitial cystitis/bladder pain syndrome.
Shih HJ; Chang CY; Lai CH; Huang CJ
Biomed Pharmacother; 2021 Jun; 138():111522. PubMed ID: 34311526
[TBL] [Abstract][Full Text] [Related]
17. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.
Yao ST; Cao F; Chen JL; Chen W; Fan RM; Li G; Zeng YC; Jiao S; Xia XP; Han C; Ran QS
J Mol Neurosci; 2017 Mar; 61(3):385-395. PubMed ID: 27933491
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
20. IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis.
Chi HH; Hua KF; Lin YC; Chu CL; Hsieh CY; Hsu YJ; Ka SM; Tsai YL; Liu FC; Chen A
J Am Soc Nephrol; 2017 Jul; 28(7):2022-2037. PubMed ID: 28179433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
